European Union -
Norwegian -
EMA (European Medicines Agency)
elfabrio
chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry sykdom - andre alimentary tract and metabolism products, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).
Norway -
Norwegian -
Statens legemiddelverk
imurel 50 mg
aspen pharma trading limited - azatioprin - tablett, filmdrasjert - 50 mg
Norway -
Norwegian -
Statens legemiddelverk
imurel 25 mg
aspen pharma trading limited - azatioprin - tablett, filmdrasjert - 25 mg
Norway -
Norwegian -
Statens legemiddelverk
vancomycin strides 125 mg
strides pharma (cyprus) limited - vankomycinhydroklorid - kapsel, hard - 125 mg
Norway -
Norwegian -
Statens legemiddelverk
natriumklorid noridem 9 mg/ ml
noridem enterprises ltd. - natriumklorid - injeksjonsvæske, oppløsning - 9 mg/ ml
Norway -
Norwegian -
Statens legemiddelverk
nicorette 2 mg
mcneil sweden ab - nikotinresinat - sugetablett, komprimert med mintsmak - 2 mg
Norway -
Norwegian -
Statens legemiddelverk
nicorette 4 mg
mcneil sweden ab - nikotinresinat - sugetablett, komprimert med mintsmak - 4 mg
Norway -
Norwegian -
Statens legemiddelverk
puri-nethol 50 mg
aspen pharma trading limited - merkaptopurin - tablett - 50 mg
Norway -
Norwegian -
Statens legemiddelverk
zyban 150 mg
glaxosmithkline as - bupropionhydroklorid - depottablett - 150 mg
Norway -
Norwegian -
Statens legemiddelverk
nicorette 2 mg
mcneil sweden ab - nikotinresinat - sugetablett, komprimert med fruktsmak - 2 mg